U.S. Earnings Preview: After Market Close Aug. 26
Dow Jones2026/08/26 19:31This article was automatically generated by Dow Jones using technology from Automated Insights.
The following companies are among those expected to report their latest financial results after the market closes.
NVIDIA Corp.'s second-quarter EPS is forecast at $2.11, compared with $1.08 in the prior-year period. Adjusted EPS is forecast at $2.09.
CrowdStrike Holdings Inc.'s second-quarter EPS is forecast at 0 cents, compared with a loss of 8 cents in the prior-year period. Adjusted EPS is forecast at 29 cents.
Salesforce Inc.'s second-quarter EPS is forecast at $1.79, compared with $1.96 in the prior-year period. Adjusted EPS is forecast at $3.27.
Synopsys Inc.'s third-quarter EPS is forecast at 90 cents, compared with $1.50 in the prior-year period. Adjusted EPS is forecast at $3.67.
Agilent Technologies Inc.'s third-quarter EPS is forecast at $1.31, compared with $1.18 in the prior-year period. Adjusted EPS is forecast at $1.49.
Veeva Systems Inc.'s second-quarter EPS is forecast at $1.56, compared with $1.19 in the prior-year period. Adjusted EPS is forecast at $2.22.
Everpure Inc.'s second-quarter EPS is forecast at 21 cents, compared with 14 cents in the prior-year period. Adjusted EPS is forecast at 58 cents.
HP Inc.'s third-quarter EPS is forecast at 63 cents, compared with 80 cents in the prior-year period. Adjusted EPS is forecast at 66 cents.
Okta Inc.'s second-quarter EPS is forecast at 37 cents, compared with 37 cents in the prior-year period. Adjusted EPS is forecast at 97 cents.
Nutanix Inc.'s fourth-quarter EPS is forecast at 23 cents, compared with 13 cents in the prior-year period. Adjusted EPS is forecast at 49 cents.
Urban Outfitters Inc.'s second-quarter EPS is forecast at $1.71, compared with $1.58 in the prior-year period. Adjusted EPS is forecast at $1.72.
Phibro Animal Health Corp.'s fourth-quarter EPS is forecast at 64 cents. Adjusted EPS is forecast at 71 cents.
Ooma Inc.'s second-quarter EPS is forecast at 10 cents, compared with 4 cents in the prior-year period. Adjusted EPS is forecast at 33 cents.
Domo Inc.'s second-quarter EPS is forecast at a loss of 31 cents, compared with a loss of 56 cents in the prior-year period. Adjusted EPS is forecast at 0 cents.
Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.
(END) Dow Jones Newswires
August 26, 2026 15:31 ET (19:31 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.